2009
DOI: 10.2807/ese.14.40.19349-en
|View full text |Cite
|
Sign up to set email alerts
|

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009

Abstract: The first two Klebsiella pneumoniae carbapenemase-producing (KPC) type 2 strains carrying ST258 were detected in Finland in June and early August 2009. They were found colonising two patients transferred from the Mediterranean; one patient referred from a hospital in Greece where isolates were first found in 2007 and another from Italy where the first isolates have been described only very recently.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…ESBL-producing microbes can be identified using a chromogenic combination. All non-ESBL-producing bacteria are inhibited by the supplement ( ceftazidime 1.50 mg, cefotaxime 1.50mg , ceftriazone 1.00mg, Aztreonam 1.00mg, fluconazole 5.00 mg additional to 500ml chromogenic media [11].…”
Section: Multi-drug Resistance Of K Pneumoniae Isolatesmentioning
confidence: 99%
See 1 more Smart Citation
“…ESBL-producing microbes can be identified using a chromogenic combination. All non-ESBL-producing bacteria are inhibited by the supplement ( ceftazidime 1.50 mg, cefotaxime 1.50mg , ceftriazone 1.00mg, Aztreonam 1.00mg, fluconazole 5.00 mg additional to 500ml chromogenic media [11].…”
Section: Multi-drug Resistance Of K Pneumoniae Isolatesmentioning
confidence: 99%
“…The phenotypic and genetic features of Klebsiella isolates recovered from healthy and unwell babies showed no change [20] The development and spread of ESBL among Gram-negative bacteria and possible horizontal transfer calls for concern, especially in view of treatment failure, high treatment cost, and consequent discomfort to patients. The early detection of ESBL-producing bacteria carriers is essential to minimize their impact and spread [11].…”
Section: Phenotypic Detection Of β-mentioning
confidence: 99%